[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ultra Nasdaq Biotechnology 2X ETF (BIB)

Ultra Nasdaq Biotechnology 2X ETF (BIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Proshare Advisors LLC
  • Assets Under Management 88,676,000
  • Shares Outstanding, K 830
  • 60-Month Beta 1.19
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.49 (0.46%)
  • Most Recent Dividend 0.007 on 03/25/26
  • Net Expense Ratio 0.95%

Options Overview Details

View History
  • Implied Volatility 45.93% (+2.57%)
  • Historical Volatility 44.56%
  • IV Percentile 45%
  • IV Rank 36.53%
  • IV High 62.30% on 03/27/26
  • IV Low 36.51% on 08/12/25
  • Expected Move (DTE 14) 2.55 (2.39%)
  • Put/Call Vol Ratio 0.41
  • Today's Volume 62
  • Volume Avg (30-Day) 15
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 233
  • Open Int (30-Day) 182
  • Expected Range 104.29 to 109.39

Price Performance

See More
Period Period Low Period High Performance
1-Month
76.06 +40.47%
on 06/03/26
106.92 -0.08%
on 07/02/26
+30.15 (+39.31%)
since 06/02/26
3-Month
75.72 +41.10%
on 05/19/26
106.92 -0.08%
on 07/02/26
+25.07 (+30.66%)
since 04/02/26
52-Week
46.38 +130.35%
on 07/07/25
106.92 -0.08%
on 07/02/26
+58.93 (+123.00%)
since 07/02/25

Most Recent Stories

More News
Lifeline For 23andMe? Stock Jumps After Court Greenlights Bankruptcy Asset Sale, Retail Weighs Possible Rescue Deals

Stocktwits users spotted a media report about Richard Magides, the director of Singapore-based Zentree Investment and 23andMe's second-largest shareholder, expressing interest in backing a rescue effort....

VHT : 308.41 (+2.52%)
ME : 0.6063 (-21.26%)
VTI : 368.76 (-0.14%)
BIB : 106.84 (+6.03%)
Tonix Pharma Dominates Retail Biotech Buzz After 1-for-100 Reverse Split, Sentiment Turns Neutral Amid Volatility

Short interest in the stock has grown steadily since mid-December, rising from 0.9% to 8.5% by the end of January, according to Koyfin data.

TNXP : 12.34 (-0.80%)
VXF : 243.24 (-0.67%)
VTI : 368.76 (-0.14%)
BIB : 106.84 (+6.03%)
Small-Cap NRx Pharma’s Stock Draws Heavy Retail Buzz After Securing $27M Funding

Chairman Jonathan Javitt said the resources committed are expected to bring NRx to the $100 million revenue threshold.

PSIL : 23.23 (+2.15%)
VXF : 243.24 (-0.67%)
NRXP : 3.87 (+0.26%)
BIB : 106.84 (+6.03%)
BeiGene Stock Eyes 2-Week High After EU Approves Cancer Treatment: Retail Enthusiasm Grows

The latest approval adds to BeiGene’s momentum, marking six EU indications granted in just over a year.

BGNE : 184.71 (+0.49%)
FBT : 255.37 (+2.45%)
BIB : 106.84 (+6.03%)
QQQJ : 45.42 (-0.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 80%. The market has entered extreme overbought territory.

See More Share

Fund Summary

The ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the NASDAQ Biotechnology Index.

See More

Top 10 Holdings

Name % Holdings
NASDAQ Bio Index SWAP BNP Paribas 0.00%
NASDAQ Biotechnology Index SWAP Bank of America NA 0.00%
NASDAQ Biotechnology Index SWAP Citibank NA 0.00%
NASDAQ Biotechnology Index SWAP Goldman Sachs International 0.00%
NASDAQ Biotechnology Index SWAP Societe Generale 0.00%
NASDAQ Biotechnology Index SWAP UBS AG 0.00%
Proshares Genius Money Market ETF 0.00%
Vertex Pharmaceutic 0.00%
Amgen Inc 0.00%
Gilead Sciences Inc 0.00%

See More

Key Turning Points

3rd Resistance Point 111.09
2nd Resistance Point 109.01
1st Resistance Point 107.92
Last Price 106.84
1st Support Level 104.75
2nd Support Level 102.67
3rd Support Level 101.58

See More

52-Week High 106.92
Last Price 106.84
Fibonacci 61.8% 83.79
Fibonacci 50% 76.65
Fibonacci 38.2% 69.51
52-Week Low 46.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.